Defeminization of brain functions by a single injection of estrogen receptor α or β agonist in neonatal female rats

Moeko Kanaya, Korehito Yamanouchi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Sexual differentiation of brain function is regulated by estrogen in the perinatal period of rodents. However, the role of the estrogen receptor subtypes ERα and ERβ is still in question. Accordingly, the effects of neonatal treatment with the ERα agonist propyl pyrazole triol (PPT) or the ERβ agonist diarylpropionitrile (DPN) on female reproductive functions were investigated in rats. Female rats were injected subcutaneously with 100-500 μg/10 g body weight (b.w.) PPT or DPN, 100 μg/10 g b.w. estradiol (E 2), or saline at day 5 (birth day = day 1), and then vaginal opening and vaginal smears were examined. On day 60, their ovaries were removed and lordosis behavior was observed after subcutaneous implantation of a silicon tube containing E 2. As a result, in most PPT and all E 2 rats, vaginal opening was advanced and an irregular estrous cycle was observed. In contrast, in most rats of the DPN groups, vaginal opening was comparable to that of the control and there was a regular estrous cycle. Lordosis tests revealed that the mean lordosis quotients (LQs) in the 250- and 500-μg PPT groups was lower than in the saline group, but higher than in the E 2 group. Mean LQs in all DPN groups were comparable to those in the saline group. These results suggest that ERα plays a major role in masculinization of the system regulating the estrous cycle in the rat brain. In behavioral defeminization of the lordosis-regulation system, ERα was also found to be the main target of estrogen.

Original languageEnglish
Pages (from-to)297-304
Number of pages8
JournalNeuroendocrinology
Volume95
Issue number4
DOIs
Publication statusPublished - 2012 Jun

Fingerprint

Lordosis
Estrogens
Estrous Cycle
Injections
Brain
Body Weight
Sex Differentiation
Vaginal Smears
Silicon
Estrogen Receptors
Ovary
Estradiol
Rodentia
Parturition
1,3,5-tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole
diarylpropionitrile

Keywords

  • Estrogen receptor agonists
  • Estrogen receptor subtypes
  • Estrous cycle
  • Lordosis
  • Sexual differentiation

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Endocrine and Autonomic Systems
  • Cellular and Molecular Neuroscience

Cite this

Defeminization of brain functions by a single injection of estrogen receptor α or β agonist in neonatal female rats. / Kanaya, Moeko; Yamanouchi, Korehito.

In: Neuroendocrinology, Vol. 95, No. 4, 06.2012, p. 297-304.

Research output: Contribution to journalArticle

@article{10ab19d32fea4374a836bcb3a94876e5,
title = "Defeminization of brain functions by a single injection of estrogen receptor α or β agonist in neonatal female rats",
abstract = "Sexual differentiation of brain function is regulated by estrogen in the perinatal period of rodents. However, the role of the estrogen receptor subtypes ERα and ERβ is still in question. Accordingly, the effects of neonatal treatment with the ERα agonist propyl pyrazole triol (PPT) or the ERβ agonist diarylpropionitrile (DPN) on female reproductive functions were investigated in rats. Female rats were injected subcutaneously with 100-500 μg/10 g body weight (b.w.) PPT or DPN, 100 μg/10 g b.w. estradiol (E 2), or saline at day 5 (birth day = day 1), and then vaginal opening and vaginal smears were examined. On day 60, their ovaries were removed and lordosis behavior was observed after subcutaneous implantation of a silicon tube containing E 2. As a result, in most PPT and all E 2 rats, vaginal opening was advanced and an irregular estrous cycle was observed. In contrast, in most rats of the DPN groups, vaginal opening was comparable to that of the control and there was a regular estrous cycle. Lordosis tests revealed that the mean lordosis quotients (LQs) in the 250- and 500-μg PPT groups was lower than in the saline group, but higher than in the E 2 group. Mean LQs in all DPN groups were comparable to those in the saline group. These results suggest that ERα plays a major role in masculinization of the system regulating the estrous cycle in the rat brain. In behavioral defeminization of the lordosis-regulation system, ERα was also found to be the main target of estrogen.",
keywords = "Estrogen receptor agonists, Estrogen receptor subtypes, Estrous cycle, Lordosis, Sexual differentiation",
author = "Moeko Kanaya and Korehito Yamanouchi",
year = "2012",
month = "6",
doi = "10.1159/000332128",
language = "English",
volume = "95",
pages = "297--304",
journal = "Neuroendocrinology",
issn = "0028-3835",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Defeminization of brain functions by a single injection of estrogen receptor α or β agonist in neonatal female rats

AU - Kanaya, Moeko

AU - Yamanouchi, Korehito

PY - 2012/6

Y1 - 2012/6

N2 - Sexual differentiation of brain function is regulated by estrogen in the perinatal period of rodents. However, the role of the estrogen receptor subtypes ERα and ERβ is still in question. Accordingly, the effects of neonatal treatment with the ERα agonist propyl pyrazole triol (PPT) or the ERβ agonist diarylpropionitrile (DPN) on female reproductive functions were investigated in rats. Female rats were injected subcutaneously with 100-500 μg/10 g body weight (b.w.) PPT or DPN, 100 μg/10 g b.w. estradiol (E 2), or saline at day 5 (birth day = day 1), and then vaginal opening and vaginal smears were examined. On day 60, their ovaries were removed and lordosis behavior was observed after subcutaneous implantation of a silicon tube containing E 2. As a result, in most PPT and all E 2 rats, vaginal opening was advanced and an irregular estrous cycle was observed. In contrast, in most rats of the DPN groups, vaginal opening was comparable to that of the control and there was a regular estrous cycle. Lordosis tests revealed that the mean lordosis quotients (LQs) in the 250- and 500-μg PPT groups was lower than in the saline group, but higher than in the E 2 group. Mean LQs in all DPN groups were comparable to those in the saline group. These results suggest that ERα plays a major role in masculinization of the system regulating the estrous cycle in the rat brain. In behavioral defeminization of the lordosis-regulation system, ERα was also found to be the main target of estrogen.

AB - Sexual differentiation of brain function is regulated by estrogen in the perinatal period of rodents. However, the role of the estrogen receptor subtypes ERα and ERβ is still in question. Accordingly, the effects of neonatal treatment with the ERα agonist propyl pyrazole triol (PPT) or the ERβ agonist diarylpropionitrile (DPN) on female reproductive functions were investigated in rats. Female rats were injected subcutaneously with 100-500 μg/10 g body weight (b.w.) PPT or DPN, 100 μg/10 g b.w. estradiol (E 2), or saline at day 5 (birth day = day 1), and then vaginal opening and vaginal smears were examined. On day 60, their ovaries were removed and lordosis behavior was observed after subcutaneous implantation of a silicon tube containing E 2. As a result, in most PPT and all E 2 rats, vaginal opening was advanced and an irregular estrous cycle was observed. In contrast, in most rats of the DPN groups, vaginal opening was comparable to that of the control and there was a regular estrous cycle. Lordosis tests revealed that the mean lordosis quotients (LQs) in the 250- and 500-μg PPT groups was lower than in the saline group, but higher than in the E 2 group. Mean LQs in all DPN groups were comparable to those in the saline group. These results suggest that ERα plays a major role in masculinization of the system regulating the estrous cycle in the rat brain. In behavioral defeminization of the lordosis-regulation system, ERα was also found to be the main target of estrogen.

KW - Estrogen receptor agonists

KW - Estrogen receptor subtypes

KW - Estrous cycle

KW - Lordosis

KW - Sexual differentiation

UR - http://www.scopus.com/inward/record.url?scp=84862775880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862775880&partnerID=8YFLogxK

U2 - 10.1159/000332128

DO - 10.1159/000332128

M3 - Article

C2 - 22327340

AN - SCOPUS:84862775880

VL - 95

SP - 297

EP - 304

JO - Neuroendocrinology

JF - Neuroendocrinology

SN - 0028-3835

IS - 4

ER -